Literature DB >> 12508173

[LithoRisk: A software for calculating and visualising nephrolithiasis risk profiles].

M Marangella1, M Petrarulo, P G Daniele, S Sammartano.   

Abstract

BACKGROUND: The pathogenesis of nephrolithiasis, based on the anomalies of the urinary environment, demands metabolic and physicochemical assessment for the medical management of patients. Standard metabolic protocols include the measurement of pertinent urine chemistry values and the calculation of the extent of saturation in stone-forming salts. However, patients are often given fragmentary and hard-to-consult reports and so this weakens the strength of the therapeutic recommendations. This paper introduces LithoRisk, a dedicated software which graphically represents risk profiles of stone formation, including the extent of saturation.
METHODS: LithoRisk uses the results of 24-h urine chemistry values widely available in hospital laboratories, i.e., sodium, potassium, calcium, magnesium, ammonia, phosphate, sulphate, citrate, oxalate, chloride, pH and urine volume. Uric acid and cystine are optional. The relative supersaturation (beta), estimated according to our own ab initio calculation, is given in a scale whereby beta=1 is saturation, beta < 1 under - and beta > 1 oversaturation. LithoRisk is available as a CD-ROM and can be loaded on Windows 95/98/Millenium/XP. Colour or laser printers are suitable for printed records.
RESULTS: LithoRisk is easily loaded on any PC by following video instructions. Once the loading of the program is completed a grey icon LithoRisk appears on the Desktop. The program can be opened by clicking twice on the icon. The patients data page first appears on the screen and is followed by the evaluation page for the input of variables. This generates the graph representing the diagnostic lithorisk profile, which is drawn as a line connecting different values, according to a specific scale and related to an arbitrary normal point. Normal values are shown as green lines, whereas abnormal ones are red. The beta values for calcium oxalate and phosphate, uric acid and cystine are instantaneously calculated and reported on the graph.
CONCLUSIONS: LithoRisk produces a complete, unique and easy to understand report that includes all relevant parameters, it therefore expresses the overall risk of stone formation. It requires the results of chemistry tests done on the same 24-h urine collection, and carried out using suitable preservatives. If the tests for unusual parameters, i.e. sulphate and ammonia, are unavailable, one can use default values with minimal alterations on beta calculation. In spite of being arbitrary, the normal thresholds values are based on widely accepted literature data. The risk profile recognises the most relevant abnormalities and enables the establishment of individual targets aimed at reducing the propensity towards stone formation.

Entities:  

Mesh:

Year:  2002        PMID: 12508173

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  7 in total

1.  Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients.

Authors:  Sanaz Tavasoli; Maryam Taheri; Fatemeh Taheri; Abbas Basiri; Fahimeh Bagheri Amiri
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

2.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

3.  Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; Marc Grynpas; Amy VandenEynde; John R Asplin; Kevin K Frick; Min Ho Kim; Felix M Ramos; Ignacio Granja; David A Bushinsky
Journal:  Nephron       Date:  2019-02-06       Impact factor: 2.847

4.  Effect of water composition and timing of ingestion on urinary lithogenic profile in healthy volunteers: a randomized crossover trial.

Authors:  Pietro Manuel Ferraro; Rocco Baccaro; Silvia Baroni; Ludovica D'Alessandri; Claudio Carpenito; Nicola Di Daniele; Andrea Urbani; Giovanni Gambaro
Journal:  J Nephrol       Date:  2020-06-08       Impact factor: 3.902

5.  Effect of vitamin D supplementation on 24-hour urine calcium in patients with calcium Urolithiasis and vitamin D deficiency.

Authors:  Maryam Taheri; Sanaz Tavasoli; Fatemeh Shokrzadeh; Fahimeh Bagheri Amiri; Abbas Basiri
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 1.541

6.  LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.

Authors:  Martino Marangella; Michele Petrarulo; Corrado Vitale; Piergiuseppe Daniele; Silvio Sammartano
Journal:  Urolithiasis       Date:  2020-11-27       Impact factor: 3.436

7.  Urine and stone analysis for the investigation of the renal stone former: a consensus conference.

Authors:  James C Williams; Giovanni Gambaro; Allen Rodgers; John Asplin; Olivier Bonny; Antonia Costa-Bauzá; Pietro Manuel Ferraro; Giovanni Fogazzi; Daniel G Fuster; David S Goldfarb; Félix Grases; Ita P Heilberg; Dik Kok; Emmanuel Letavernier; Giuseppe Lippi; Martino Marangella; Antonio Nouvenne; Michele Petrarulo; Roswitha Siener; Hans-Göran Tiselius; Olivier Traxer; Alberto Trinchieri; Emanuele Croppi; William G Robertson
Journal:  Urolithiasis       Date:  2020-10-13       Impact factor: 3.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.